Authors
Binbin Zhao, Xuejiao Cui
Published in
Autoimmunity reviews. Pages 104203. Oct 26, 2026. Epub Oct 26, 2026.
Abstract
The Hippo signaling pathway is traditionally regarded as a key regulator of cancer initiation and progression. However, accumulating evidence indicates that the Hippo signaling pathway is also closely associated with the onset and progression of autoimmune diseases. Dysregulation of Hippo signaling in immune cells may disrupt immune homeostasis, thereby increasing susceptibility to autoimmune disorders. This review summarizes recent advances in understanding the role of the Hippo signaling pathway in immune cells and autoimmune diseases, and highlights the potential of targeting Hippo signaling as a novel therapeutic strategy for autoimmune diseases.
PMID:
42933745
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0